Continuum Advisory, LLC Vertex Pharmaceuticals Inc Transaction History
Continuum Advisory, LLC
- $778 Million
- Q3 2024
A detailed history of Continuum Advisory, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Continuum Advisory, LLC holds 1,565 shares of VRTX stock, worth $718,335. This represents 0.09% of its overall portfolio holdings.
Number of Shares
1,565
Previous 1,681
6.9%
Holding current value
$718,335
Previous $787,000
7.62%
% of portfolio
0.09%
Previous 0.12%
Shares
13 transactions
Others Institutions Holding VRTX
# of Institutions
1,745Shares Held
227MCall Options Held
1.53MPut Options Held
1.4M-
Capital World Investors Los Angeles, CA28.3MShares$13 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$10.7 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.78 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$5.5 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$4.79 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $118B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...